At both 7 and 14 days, the gene expression of relevant factors in the PET/PDA/dECM group was comparable to or significantly higher than that in the TCPS group, and, except for TGF-β and VEGF, all other factor expressions were significantly higher than in the PET/PDA group. This evidence concerns the gene TGFB1 and Patent ductus arteriosus.